XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The provision for income taxes consists of the following (in thousands):
Year Ended December 31,
20222021
Current:
Federal$— $— 
State24 27 
Total current24 27 
Deferred:
Federal(137)137 
State(169)11 
Total deferred(306)148 
Provision (benefit) for income tax$(282)$175 
Schedule of Effective Income Tax Rate Reconciliation
The effective tax rate of our provision for income taxes differs from the federal statutory rate as follows:
Year Ended December 31,
20222021
Federal statutory tax rate(21.0)%(21.0)%
State income taxes, net of federal tax benefits(4.3)%(3.8)%
Research and development tax credits(1.5)%(1.2)%
Stock compensation1.4 %0.9 %
Non-deductible expenses0.9 %1.1 %
Change in valuation allowance23.9 %24.6 %
Effective tax rate(0.6)%0.6 %
Schedule of Deferred Tax Assets and Liabilities If the Company’s judgment changes and it is determined that the Company will be able to realize these deferred tax assets, the tax benefits relating to any reversal of the valuation allowance on deferred tax assets will be accounted for as a reduction to income tax expense.
December 31,
20222021
Deferred tax assets:
Net operating loss carryforwards$29,789 $22,365 
Research and development tax credits2,216 1,102 
Accruals, reserves and other349 1,055 
Interest expense2,236 1,953 
Indefinite lived assets362 — 
Stock compensation1,606 1,407 
Lease liability1,374 — 
Capitalization of research and experimentation costs2,047 — 
Total gross deferred tax assets39,979 27,882 
Less: valuation allowance(38,567)(27,158)
Deferred tax assets, net1,412 724 
Deferred tax liabilities:
Financing and acquisition-related liabilities— (335)
Indefinite lived assets— (521)
Right of use assets(1,206)— 
Basis differences in fixed and intangible assets(206)(175)
Deferred tax liabilities, net(1,412)(1,031)
Net deferred tax liabilities$— $(307)
Summary of Valuation Allowance Changes in the valuation allowance for deferred tax assets during the years ended December 31, 2022 and 2021, which related primarily to increases in net operating loss (NOL) carryforwards, research and development tax credits, capitalization of research and experimentation costs, and impairment of goodwill were as follows (in thousands):
December 31,
20222021
Valuation allowance at the beginning of the year$27,158 $20,596 
Increases recorded to income tax provision11,409 6,562 
Valuation allowance at the end of the year$38,567 $27,158